AOD-9604

A GROWTH HORMONE-DERIVED METABOLIC FRAGMENT

AOD-9604 is a synthetic fragment of human growth hormone (hGH 177-191 + Tyr) originally developed to harness hGH’s fat-modulating effects without its impact on IGF-1 or glucose metabolism. Preclinical research suggests favorable effects on fat oxidation, lipolysis, and weight gain, and human trials have primarily focused on safety and metabolism rather than confirmed weight-loss efficacy. AOD-9604 is approached as an experimental adjunct under strict medical oversight at Huemn.

Get Approved

the ultimate fat burner

Here’s are the potential benefits of AOD-9604, based on current evidence.

  • Supports Fat Metabolism: Helps the body break down stored fat more efficiently, especially when paired with healthy habits.

  • Encourages Natural Lipolysis: Signals fat cells to release fat for energy rather than store it.

  • May Reduce New Fat Storage: Early research suggests AOD-9604 may help slow the rate at which new fat is deposited.

  • Does Not Affect IGF-1 Levels: Works independently of traditional growth hormone pathways, offering metabolic support without hormonal elevation.

  • Generally Well-Tolerated: Studies show AOD-9604 is typically gentle on the system with a favorable short-term safety profile.

Medical professional discussing medication with patient in clinic
os-01 peptide therapy, os-01 peptides houst, os-01 treatments in houston, os-01 for skin, os-01 skin health

Relevant Studies

Read below for studies endorsing AOD-9604.

  1. Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans (Journal of Endocrinology and Metabolism, 2013)

  2. Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health (Journal of Endocrinology and Metabolism, 2014)

FAQs

  • Short-term trials suggest AOD-9604 has a safety and tolerability profile similar to placebo, with no significant effects on IGF-1, no impairment in glucose tolerance, and no anti-AOD-9604 antibodies detected.

  • No. AOD-9604 is not approved by the FDA (or other major regulators) for weight loss, obesity, or any medical indication. It has also been removed from certain FDA bulk-compounding lists, and regulators have cautioned against its use in compounded products.

  • AOD-9604 is given as a subcutaneous injection.

  • In theory, AOD-9604 has been explored for people with obesity or metabolic issues, but given the lack of clear efficacy and the regulatory stance, it’s best considered experimental at this point. Anyone pregnant, breastfeeding, with significant metabolic, cardiac, or autoimmune disease, or taking multiple medications should be especially cautious and only consider it, if at all, within a properly supervised research/clinical framework.

nad+ injections, nad+ near me, nad+ houston, nad+ injections houston tx

Huemn offers AOD-9604 peptide therapy in Houston, serving clients from The Heights, Vintage Park, Cypress, and surrounding areas seeking advanced immune and longevity support.

Disclaimer: The statements and content presented on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). We do not diagnose, treat, or claim to treat any health conditions. All services provided by Huemn are intended solely to promote overall wellness, and information on this site is published for educational purposes. Always consult with a healthcare professional before making any decisions related to your health.